Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and electrophilic carbonyls (ECs) are highly reactive chemical entities produced during normal cellular metabolism or under conditions of oxidative and carbonyl stress [1]. ROS include oxygen-derived free radicals and non-radicals like hydrogen peroxide, while ECs, often termed reactive carbonyl species (RCS), include alpha,beta-unsaturated aldehydes like 4-hydroxynonenal (4-HNE) and dicarbonyls like methylglyoxal [2]. While they serve as important signaling molecules at physiological levels, their accumulation leads to irreversible damage to proteins, lipids, and DNA, contributing to the pathogenesis of various chronic conditions including neurodegeneration, cardiovascular disease, and diabetes [3]. Therapeutic strategies targeting these species involve direct scavenging by antioxidants or the use of "carbonyl trappers" like hydralazine and carnosine to prevent the formation of advanced glycation end-products (AGEs) and advanced lipoxidation end-products (ALEs) [4]. Additionally, drugs may target the enzymatic sources of these species, such as NADPH oxidases, or upregulate endogenous defense mechanisms via the Nrf2 pathway [5]. [1] Sies, H., & Jones, D. P. (2020). Nature Reviews Molecular Cell Biology. [2] Schaur, R. J., et al. (2015). Biomolecules. [3] Pizzino, G., et al. (2017). Oxidative Medicine and Cellular Longevity. [4] Negre-Salvayre, A., et al. (2008). Antioxidants & Redox Signaling. [5] Forman, H. J., & Zhang, H. (2021). Nature Reviews Drug Discovery.
Direct chemical neutralization (scavenging) of reactive oxygen and carbonyl species, inhibition of oxidative enzymes, and activation of endogenous antioxidant pathways.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and electrophilic carbonyls (ROS/RCS).